Bloomberg: Twist Bioscience announces Microsoft Purchase of its synthetic DNA for digital data storage research
Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, announced Microsoft has agreed to purchase ten million long oligonucleotides from Twist Bioscience to encode digital data. Doug Carmean, Microsoft Partner Architect, Technology and Research organization, Microsoft, said, “As our digital data continues to expand exponentially, we need new methods for long-term, secure data storage. The initial test phase with Twist demonstrated that we could encode and recover 100 percent of the digital data from synthetic DNA. We’re still years away from a commercially- viable product, but our early tests with Twist demonstrate that in the future we’ll be able to substantially increase the density and durability of data storage.”